<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Moderna stock is up by about 2.5x year-to-date, trading at levels of about $390 per share as of Friday. The rally comes on the back of Moderna’s recent inclusion into the S&P 500 index and the emergence of new virus variants which are making a strong case for booster doses of Covid-19 shots.
...read full article on Forbes
